A startup logo at a Jake Paul fight? It wasn’t a fluke. Kian breaks down how Nucleus landed on national screens using a moment most corporations couldn’t move fast enough to touch. No big budget. No traditional sponsorships. Just speed, strategy, and relentlessness. Watch this if you want to learn how to hijack attention with precision.

Start with Kian describing how he decides what products to trust: observing his own buying behavior while comparing food planning companies. Then jump straight to the insight—he gravitated most toward the company where the founder spoke directly to camera, shared sourcing, and felt 'real.' Cut to Kian tying that realization back to Nucleus: When consumers are choosing a genetic testing company, they don’t just choose based on specs—they choose trust, and trust comes from seeing a real person behind the brand. End on the punch: If you’re a founder and you’re not building a public connection, you’re falling behind. Today, the line between founder and influencer doesn’t exist. The strongest founders are showing up in the feed.

Every genetic test you've heard of? We combined them into one. Over 70,000 separate tests—all collapsed into a single, ultra-comprehensive DNA test. Here's the wild part: it only became possible because the cost of sequencing a genome dropped from $100 million to $1,000. That shift changed everything. We’re not guessing based on one page of your DNA. We’re reading the whole book, front to back.

Fifty rejections. No PhD. No fancy background. Kian’s just a guy in his bedroom, pitching his heart out. He sends a cold text off a patent search rabbit hole. Gets ghosted. Sends it again. And suddenly, he’s on the phone with a top founder—gets grilled, still holding the pitch. Two days later, boom. $1.5 million wired while his mom walks in like she knew. That’s not luck. That’s obsession.

Founder hits rock bottom, stuck in his bedroom, no experience, no money. Then someone wires him $1.5M. Flash forward: the Nucleus logo is in lights at a global event, right next to his baby photo. The wildest part? That moment proves something deep. Reality can bend if you keep going. That's the real founder high.

When Nucleus appeared on screen at the Jake Paul fight, it wasn't luck. It was the result of speed, precision, and an unconventional understanding of media cycles—and how to hack them.

Four days before the event, no Fortune 500 company could’ve pulled off a sponsorship. Legal departments, slow procurement, and corporate layers would stall any deal until the fight was long over. But startups play by different rules. We had what giant companies don’t: decision-making velocity.

We negotiated directly with a key trainer in Jake Paul’s corner. And while a hat might seem like a small canvas, we treated it like prime-time real estate. The design mattered. Messaging clarity mattered. Placement and timing mattered. The goal: embed the Nucleus brand into a pop culture moment that millions would screenshot, repost, and ask, 'What is that logo?'

But here’s the deeper insight for founders: with these kinds of brand stunts, the win isn’t just awareness. The win is feeding top-of-funnel velocity that stacks. We hit a spike in SEO rankings. Traffic surged. Investors noticed. Even legacy media picked it up.

It’s not about being gimmicky. It’s about executing opportunistic moves that embed your mission into the broader cultural conversation. For Nucleus, that moment wasn’t just about a logo on screen. It was a declaration: we’re here to make America healthier, and we’re not waiting for permission to be seen.

There are more than 70,000 genetic tests on the market today. Most of them analyze just fragments of your DNA—one page, maybe one paragraph out of the thousand-page book that is your genome. That fragmented approach made sense when sequencing DNA cost tens of millions of dollars. But the game changed. The cost to sequence an entire genome has fallen from $100 million to under $1,000 in just two decades, and continued innovation is pushing it even lower.

At Nucleus, we realized this meant one thing: stop looking at scattered data points and start using the full picture. We built a test that analyzes your entire genome and integrates the functional insights of over 70,000 discrete tests into a single, unified platform. This isn't incremental improvement. It's healthcare intelligence at a scale that wasn’t possible before.

What changed? Automation, parallel sequencing, algorithmic advances, and—most importantly—an exponential increase in available genomic data. With the Human Genome Project as a foundation, we’ve entered a new era in precision health. Your entire DNA can now be digitized, increasingly modeled, and made actionable, combining molecular biology with machine learning in ways the previous generation couldn’t touch.

We didn’t just make an all-in-one test. We created a new layer of software that can finally meet the depth of the underlying biology. Think of it as going from dial-up to fiber optic broadband—but for your health data.

If you're still using tests that skim the surface, you're relying on insights built for the last century. It's time to upgrade.

There’s a moment in every founder’s life when the weight of the journey hits you — not as burnout, but as disbelief. I had one of those moments standing at a Jake Paul fight. The ring lights hit, the jumbotron lit up, and there it was: the Nucleus logo. My baby photo, our brand, beaming into a global arena. And all I could think was — this started in my bedroom with nothing but an idea and a laptop.

Founding a biotech company shouldn’t have worked. I didn’t come from genetics. I wasn’t a serial entrepreneur. I didn’t have pedigree. But I had conviction. I had sleepless nights. I had the willingness to get mentally, emotionally, even physically wrecked to make it happen.

Raising early money from one of the most selective funding firms in Silicon Valley? That didn’t make sense on paper either. But it happened, because people saw something in what we were building. And once you see people bet on you not just with capital but with belief, it reprograms your brain. It rewires what you think is possible.

That's the core of entrepreneurship that people don’t talk nearly enough about. Not product-market fit. Not CAC. Not scaling GTM.

It's that moment when reality bends and you realize it bent because of your sheer will. It’s a kind of secular, entrepreneurial enlightenment. You built something where once there was nothing.

And in genomics, that power goes even further. We’re not just building companies. We’re building infrastructure inside human lives. We’re building meaning into data. We’re building predictive medicine, not reactive treatment.

This moment — from the bedroom to the global screen — is more than a milestone. It’s proof that when you obsess hard enough and stick with it long enough, you don’t just start a company. You change what’s even considered realistic.

Most people think raising a seed round takes prestige, a PhD, or a warm intro. I had none of it. I didn’t even have an office. What I had was a $300,000 bank balance, 50 rejections from investors, a torn-up pitch deck, and a bedroom that doubled as HQ.

What happened next was one of the most improbable turning points in my life—and the origin story of how Nucleus Genomics raised $1.5M from Founders Fund.

This wasn’t a smooth pitch process. I found a sequencing patent with a random guy's name on it. Stalked him on LinkedIn. Guessed his email. Texted him directly using a carrier-level hack. Lied that I was friends with someone we both knew. And when that didn’t work, followed up again. He finally replied. We got on a call. He asked where I got my PhD. I said, 'My bedroom.'

Minutes later he's calling Founders Fund. They bring in Delian. Five minutes into the call, Delian commits $1.5M. It happens in real time. In my bedroom. My mom barges in mid-call and somehow knows—I didn’t say anything—and just blurts out in disbelief. Some investor just wired $1.5M.

I was nobody. No resume that checked the traditional boxes. I just had a vision for the future of genomic medicine, and a relentless obsession to build it.

This is not a fundraising how-to. This is proof that when you’re working on something real, and you’re willing to go through the wall, the rules don’t apply. The only credential you need is traction toward truth.

To everyone building something out of nothing: don't underestimate that desperation can be a form of clarity. The moment you stop waiting for permission, you start making history.

Five days before the Jake Paul fight, every major sponsor was too slow to move. No legal team at a big corporation can turn around a deal that fast. But a startup can. We can move at the speed of culture. We managed to get the Nucleus logo on live national television during a viral moment—not through brute force, but by outflanking the entire industry on timing, creativity, and execution. That logo wasn’t just a brand play. It was a layered bet on media virality, search engine behavior, and brand memory. Our web traffic spiked. SEO lifted. And more Americans started recognizing our mission to make the country healthier. That’s how you build national mindshare from nothing. That’s how you build a generational brand.

If you're a founder and you're not showing your face, you're already behind.

The way we build trust has completely shifted. I was browsing meal prep companies the other day and chose the one where I could watch the founder explain where their ingredients came from. It wasn’t just a brand—it was a person I could see and listen to. That’s when it clicked.

People don’t decide based on polished branding or perfect copy anymore. They decide based on connection and clarity. They want to know who’s behind the product and why it’s worth their trust.

At Nucleus, people often tell me they chose us because they saw my videos. That’s not vanity—it’s accountability. You know who’s responsible for the science, the turnaround time, and the customer experience. You can see I care. And if you can’t build that kind of direct trust in 2024, you’re going to lose to someone who will.

There are over 70,000 genetic tests on the market. That’s not an opportunity. That’s a problem.

Each test looks at a slice of the genome. A sentence. A paragraph. A page. Which means patients are forced into a fragmented picture of their health—one test for cardiac risk, another for cancer, another for medications.

We combined all of them into one.

That’s the power of whole genome sequencing, done right. It's the full thousand pages of your DNA, not just a few lines.

When the cost of sequencing dropped from $100 million to under $1,000, it was clear: the future wasn’t just cheaper data. It was deeper insights.

That’s why we built Nucleus: the world’s most comprehensive whole genome health test. One test. All 70,000 in one. Precise, personalized, and built for the real world of chronic disease, polygenic risk, and preventive medicine.

I had $300,000 in the bank, 50 investor rejections, and no PhD—just a dorm-room vision of what genomics should become.

Then a cold text to a stranger whose name I found on a DNA sequencing patent turned into a weekend Zoom call… and that turned into a call with Founders Fund.

Five minutes into that next conversation, they said they were wiring $1.5 million.

No résumé. No insider connections. Just product obsession and a relentlessly technical pitch.

That moment changed everything for Nucleus—not because of the money, but because of what it represented: someone betting on a founder who hadn’t “earned it” on paper but refused to wait for permission.

What we’re building at Nucleus is big. There are millions of people who will one day manage their health decisions through their whole genome. No half-measures. No guesswork. That's the future we’re chasing.

And if you’re the kind of person who would’ve taken that bet too… you probably belong here.

There’s a moment I’ll never forget. I was on the floor at the Jake Paul fight, looked up, and saw a global screen with the Nucleus logo above me. My baby picture in the branding. A product we built from nothing. And I just stood there, stunned.

I remembered those nights in my room — no team, no product, just conviction. And someone, somewhere, believed enough in that conviction to wire $1.5M. That’s not just capital, that’s trust. And when it hits, it bends your sense of what’s possible.

Founding a company isn’t just a job. It rewires who you are. The startup changes you just as much as you shape it. And if you go deep enough, the line between you and the mission disappears.

To every early-stage founder out there: you’re not building a product, you’re willing your own reality into existence. And when the world starts reflecting it back to you, it’s not validation. It’s alchemy.

No one at home watching the Jake Paul fight expected to see the logo of a genomics startup next to the punches. But that’s exactly what happened. This wasn’t about luck. It was precision timing, tactical leverage, and betting on a shot no big brand could move fast enough to take. Nucleus Genomics didn’t just get a hat on TV. We hijacked a moment with a logo, a phrase, and a strategy built to bend reality. This is how you break out of the tech echo chamber and go national.

Start with a moment where Kian compares shopping for food subscriptions to choosing a genetic testing company. Move into how seeing a real founder on camera makes a brand feel trustworthy. Let Kian narrate how he applied this personal insight back to Nucleus: that people choose Nucleus because they know who’s behind it. End on the bold claim that today, if you're a founder who isn't also an influencer, you're falling behind.

What if you didn’t need thousands of separate tests to understand your DNA? What if you could actually read the full book instead of just skimming a sentence? At Nucleus, we realized: there are over 70,000 genetic tests. So we built one test that combines them all. Why? Because the cost of sequencing your entire genome dropped from $100 million to under $1,000. When I saw that shift, I dropped out, moved back to my room in Brooklyn, and started building. This isn’t just more data—it’s the most complete genetic snapshot of your health that science can offer.

A sequencing patent. A cold text. A lie about knowing Keith. One weekend call from my bedroom and a pitch to a guy who had no reason to say yes. Fifty investors had already said no. Then suddenly, in five minutes, someone wires me $1.5M. My mom bursts into the room and just knew. Instinct. That's how Nucleus got off the ground. Not with status. Not with a PhD. Just vision, persistence, and one chance moment that changed everything.

From a bedroom and nothing but a dream to watching your company’s logo on a global stage. That moment you realize the line between vision and reality has completely blurred. This is where it hits — you really bent reality to your will. It’s not about exiting. It’s not about headlines. It’s about the pure searing moment of proof: it worked.

Most founders waste their brand shot trying to look polished. We dropped a boom mic into the Jake Paul fight. Nucleus logo on national TV, guerrilla-style, at the exact second cameras hit the trainer. Zero marketing team. Zero lead time. Just speed, leverage, and timing. Now search traffic’s off the charts. You want out of the tech bubble? Build for the Zeitgeist.

If you’re a founder and you’re not building in public, you’re choosing irrelevance. People don’t trust brands anymore. They trust the person behind the product. That's why I talk directly to camera about Nucleus. That’s why people choose us. Founders are the new media.

There are over 70,000 individual genetic tests on the market. One test for cancer risk. Another for drug response. One for Alzheimer’s. One for blood disorders. We built one test that combines them all. The world’s most advanced DNA health screen is here.

I raised $1.5M from my bedroom after 50 investors said no.

No PhD, no job at Palantir, no network. Just a sequencing patent, a cold text to a stranger, and a pitch from a weekend call.

That stranger was an investor. He hung up, called his friend. Monday, we had our first seed check. Welcome to biotech.

Went from a dream in my bedroom to seeing the Nucleus logo light up the floor of the Jake Paul fight. That moment bent reality. Not because of hype or luck. Because someone wired $1.5M to an idea that didn’t exist yet. If that’s not proof of alchemy, I don’t know what is.

A Jake Paul fight. A sea of sponsorships. But somehow, a tiny biotech startup hijacks the national screen. This isn't about money. It's about timing, obsession, and hacking the slowness of big brands. Watch a founder lose his mind in real-time as Nucleus flashes on millions of TVs—then realize the whole thing was a calculated bet to outmaneuver Fortune 500s. No scripts. Just a hat, a trainer, and one unbelievably risky idea that actually worked.

Start with Kian talking about watching how he shops for new products. Cut into the moment he realizes that the brand he trusted most had an active founder directly talking to customers. He explains how this authentic connection built trust and made him want to buy. Then pivot into how he applies the same principle at Nucleus — showing up, taking personal responsibility, and staying at the front of the brand. End when he says people buy because they connect with his videos. It’s a clear arc: how founder visibility builds consumer trust, and why being on camera isn’t optional for modern founders.

Hook with the chart moment: watching the price of genome sequencing drop from $100M to $1K. Cut to Kian connecting that moment to a wild realization: every DNA test out there is just reading one page of a 1000-page book. He explains how he dropped out, filled 18 notebooks, and built a way to read the whole book—combining over 70,000 single-purpose tests into one. End with his parents threatening to kick him out and him texting a stranger online for funding. It actually worked.

Start with Kian sitting in his bedroom, describing the moment he cold-texted a stealth startup founder off a DNA patent. Zero connections. Got ignored. Texted again. Got a meeting. The next day, he’s pitching from his bedroom on a weekend. He says he’s raised $300K. The investor is shocked. A few calls later, Founders Fund wires him $1.5M. Cut to Kian’s mom walking in mid-call, somehow knowing exactly what just happened. The moment she says 'they gave you 1.5 million?'—that’s the emotional punch. End on Kian saying she just knew. This wasn’t luck. Founding Nucleus started with 50 rejections, one ballsy hack, and a mom with terrifying intuition.

Start with the moment Kian describes working from his bedroom with no money, just the dream. Jump to the vivid, surreal scene where he's at the Jake Paul fight and sees his company’s logo on a global screen. Let that moment sit. Then cut to him explaining how that’s the real high of being a founder—not the hype, not the headlines, but realizing you just bent reality. Frame it like a head-trip realization that hits founders hard when they’re deep in the grind. End with that emotional punch: this wasn’t luck, this was vision turned tangible.